HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.

Abstract
Cancer cells can overcome the ability of polyamine biosynthesis inhibitors to completely deplete their internal polyamines by the importation of polyamines from external sources. This paper discusses the development of a group of lipophilic polyamine analogues that potently inhibit the cellular polyamine uptake system and greatly increase the effectiveness of polyamine depletion when used in combination with DFMO, a well-studied polyamine biosynthesis inhibitor. The attachment of a length-optimized C(16) lipophilic substituent to the epsilon-nitrogen atom of an earlier lead compound, D-Lys-Spm (5), has produced an analogue, D-Lys(C(16)acyl)-Spm (11) with several orders of magnitude more potent cell growth inhibition on a variety of cultured cancer cell types including breast (MDA-MB-231), prostate (PC-3), melanoma (A375), and ovarian (SK-OV-3), among others. These results are discussed in the context of a possible membrane-catalyzed interaction with the extracellular polyamine transport apparatus. The resulting novel two-drug combination therapy targeting cellular polyamine metabolism has shown exceptional efficacy against cutaneous squamous cell carcinomas (SCC) in a transgenic ornithine decarboxylase (ODC) mouse model of skin cancer. A majority (88%) of large, aggressive SCCs exhibited complete or nearly complete remission to this combination therapy, whereas responses to each agent alone were poor. The availability of a potent polyamine transport inhibitor allows, for the first time, for a real test of the hypothesis that starving cells of polyamines will lead to objective clinical response.
AuthorsMark R Burns, Gerard F Graminski, Reitha S Weeks, Yan Chen, Thomas G O'Brien
JournalJournal of medicinal chemistry (J Med Chem) Vol. 52 Issue 7 Pg. 1983-93 (Apr 09 2009) ISSN: 1520-4804 [Electronic] United States
PMID19281226 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antineoplastic Agents
  • Polyamines
  • lysyl-epsilon-palmitoyl-N1-spermine
  • Spermine
  • Ornithine Decarboxylase
  • Lysine
  • Eflornithine
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, chemical synthesis, pharmacology)
  • Antineoplastic Combined Chemotherapy Protocols (pharmacology, therapeutic use)
  • Biological Transport (drug effects)
  • Carcinoma, Squamous Cell (drug therapy)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Drug Screening Assays, Antitumor
  • Eflornithine (administration & dosage)
  • Lysine (administration & dosage, analogs & derivatives, chemical synthesis, pharmacology)
  • Mice
  • Mice, Transgenic
  • Neoplasm Transplantation
  • Ornithine Decarboxylase (genetics)
  • Polyamines (antagonists & inhibitors, metabolism)
  • Skin Neoplasms (drug therapy)
  • Spermine (administration & dosage, analogs & derivatives, chemical synthesis, pharmacology)
  • Structure-Activity Relationship
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: